Skip to search.
 TSX Up 0.03% TSX Ventures Up 1.56%

Nektar Therapeutics (NKTR)

-NasdaqGS
17.34 Down 0.24(1.37%) 4:00PM EDT
|After Hours : 17.34 0.00 (0.00%) 4:55PM EDT
Prev Close:17.58
Open:17.58
Bid:16.35 x 1200
Ask:18.03 x 1200
1y Target Est:19.33
Beta:1.48408
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:16.99 - 18.01
52wk Range:9.92 - 18.70
Volume:1,038,294
Avg Vol (3m):988,236
Market Cap:2.37B
P/E (ttm):N/A
EPS (ttm):-0.97
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NKTRDown 1.37%2.37B
GSKDown 0.36%106.31B
ENZNDown 2.56%16.67M
BMYUp 0.29%98.18B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):12.59
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.11
Quarterly EPS Est (Sep-16) :-0.35
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):2.13

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Nektar Therapeutics develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. Its product pipeline includes drug candidates in therapeutic areas comprising oncology, pain, anti-infectives... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback